$4.34
-0.14-3.23%
At close: Jul 23, 6:00 PM EDT
$4.20
-0.14-3.23%
After Hours: 6:00 PM EDT
15 minutes delayed
Comments
Loading...
NeuroBo Pharmaceuticals
NRBONASDAQ
NeuroBo Pharmaceuticals (NASDAQ:NRBO) Stock, Earnings Estimates, EPS, And Revenue
NeuroBo Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 7
EPS Estimate
$-1.130
Quarterly Revenue Estimate
–
Annual Revenue
(as of Mar 31)
(as of Mar 31)
–
Analyze the earnings history of NeuroBo Pharmaceuticals using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NRBO | NeuroBo Pharmaceuticals | -$0.16 | -$1.13 | — | — | $0.00 | — | — | — | 08/07/2024 | Get Alert |
| NRBO | NeuroBo Pharmaceuticals | -$0.51 | -$1.10 | -$1.32 | -20.00% | $0.00 | — | $0.00 | — | 05/09/2024 | Get Alert |
| NRBO | NeuroBo Pharmaceuticals | -$40.16 | -$0.78 | -$1.02 | -30.77% | $0.00 | — | $0.00 | — | 03/28/2024 | Get Alert |
| NRBO | NeuroBo Pharmaceuticals | -$28.00 | -$0.88 | -$0.72 | 18.18% | $0.00 | — | $0.00 | — | 11/13/2023 | Get Alert |
| NRBO | NeuroBo Pharmaceuticals | -$29.76 | — | -$0.16 | — | $0.00 | — | $0.00 | — | 08/09/2023 | Get Alert |
| NRBO | NeuroBo Pharmaceuticals | -$26.40 | — | -$0.48 | — | $0.00 | — | $0.00 | — | 05/12/2023 | Get Alert |
| NRBO | NeuroBo Pharmaceuticals | -$40.80 | — | -$40.16 | — | $0.00 | — | $0.00 | — | 03/30/2023 | Get Alert |
| NRBO | NeuroBo Pharmaceuticals | -$38.40 | — | -$28.00 | — | $0.00 | — | $0.00 | — | 11/14/2022 | Get Alert |
| NRBO | NeuroBo Pharmaceuticals | -$43.20 | — | -$28.80 | — | $0.00 | — | $0.00 | — | 08/12/2022 | Get Alert |
| NRBO | NeuroBo Pharmaceuticals | -$36.00 | — | -$26.40 | — | $0.00 | — | $0.00 | — | 05/13/2022 | Get Alert |
| NRBO | NeuroBo Pharmaceuticals | -$288.00 | — | -$40.80 | — | $0.00 | — | $0.00 | — | 04/01/2022 | Get Alert |
| NRBO | NeuroBo Pharmaceuticals | -$45.60 | -$36.00 | -$38.40 | -6.67% | $0.00 | — | $0.00 | — | 11/15/2021 | Get Alert |
| NRBO | NeuroBo Pharmaceuticals | -$36.00 | -$36.00 | -$43.20 | -20.00% | $0.00 | — | $0.00 | — | 08/16/2021 | Get Alert |
| NRBO | NeuroBo Pharmaceuticals | -$72.00 | — | -$36.00 | — | $0.00 | — | $0.00 | — | 05/17/2021 | Get Alert |
| NRBO | NeuroBo Pharmaceuticals | -$808.80 | -$45.60 | -$288.00 | -531.58% | $0.00 | — | $0.00 | — | 04/15/2021 | Get Alert |
| NRBO | NeuroBo Pharmaceuticals | -$168.00 | -$40.80 | -$45.60 | -11.76% | $0.00 | — | $0.00 | — | 11/13/2020 | Get Alert |
| NRBO | NeuroBo Pharmaceuticals | — | -$45.60 | -$36.00 | 21.05% | — | — | $0.00 | — | 08/11/2020 | Get Alert |
| NRBO | NeuroBo Pharmaceuticals | -$115.20 | — | -$72.00 | — | — | — | $0.00 | — | 05/17/2020 | Get Alert |
| NRBO | NeuroBo Pharmaceuticals | — | — | -$808.80 | — | — | — | $0.00 | — | 02/17/2020 | Get Alert |
NeuroBo Pharmaceuticals (NRBO) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-09 | $-1.32 | $-1.10 | -20.0 % |
| Dec 2023 | 2024-03-28 | $-1.02 | $-0.78 | -30.8 % |
| Sep 2023 | 2023-11-13 | $-0.72 | $-0.88 | 18.2 % |
| Sep 2021 | 2021-11-15 | $-38.40 | $-36.00 | -6.67 % |
NeuroBo Pharmaceuticals (NRBO) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is NeuroBo Pharmaceuticals (NASDAQ:NRBO) reporting earnings?
NeuroBo Pharmaceuticals (NRBO) is scheduled to report earnings on August 7, 2024. The last reported earnings were for reported on May 9, 2024 for Q1.
What were the latest earnings per share (EPS) for NeuroBo Pharmaceuticals (NASDAQ:NRBO)?
The Actual EPS was $-1.32, which missed the estimate of $-1.10.
What were NeuroBo Pharmaceuticals’s (NASDAQ:NRBO) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.